1st Feb 2007 15:18
Oxford Biomedica PLC01 February 2007 FOR IMMEDIATE RELEASE 1 February 2007 Oxford BioMedica Extraordinary General Meeting Oxford, UK - 1 February 2007: Oxford BioMedica (LSE: OXB), a leading genetherapy company, announced today that all resolutions proposed were duly passedat the Extraordinary General Meeting held today in London. -Ends- For further information, please contact: Oxford BioMedica plc: Tel: +44 (0)1865 783 000Professor Alan Kingsman, Chief Executive City/Financial Enquiries: Tel: +44 (0)20 7466 5000Lisa Baderoon/ Mark Court/ Mary-Jane JohnsonBuchanan Communications Scientific/Trade Press Enquiries: Tel: +44 (0)20 3008 7550Katja Stout/ Gemma BradleyNorthbank Communications This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Oxford Biomedica